Thus, the expression of downstream NOX4/ROS/VEGF signaling pathway-related proteins is activated and the proliferation of breast cancer cells is increased, whereas the proliferation of breast cancer cells is inhibited in the control group with the addition of inhibitors. Here, NOX4 is linked to breast carcinoma.